Skip to main content
Contact Us
Subscribe
E-Edition
66°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by InMed Pharmaceuticals Inc.
InMed Reports Second Quarter Fiscal 2023 Financial Results and Provides Business Update
February 17, 2023
From
InMed Pharmaceuticals Inc.
Via
GlobeNewswire
Tickers
INM
InMed Submits Form 12b-25
February 09, 2023
From
InMed Pharmaceuticals Inc.
Via
GlobeNewswire
Tickers
INM
InMed Provides Business Update and Milestones for 2023
January 10, 2023
From
InMed Pharmaceuticals Inc.
Via
GlobeNewswire
Tickers
INM
InMed Announces Results of 2022 Annual General Meeting
December 15, 2022
From
InMed Pharmaceuticals Inc.
Via
GlobeNewswire
Tickers
INM
InMed Announces Appointment of Interim Chief Financial Officer and Change of Auditor
December 12, 2022
From
InMed Pharmaceuticals Inc.
Via
GlobeNewswire
Tickers
INM
InMed Pharmaceuticals Announces Closing of $6 Million Private Placement Priced at a Premium to Market
November 21, 2022
From
InMed Pharmaceuticals Inc.
Via
GlobeNewswire
Tickers
INM
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
November 18, 2022
From
InMed Pharmaceuticals Inc.
Via
GlobeNewswire
Tickers
INM
InMed Provides Update on Management Changes
November 17, 2022
From
InMed Pharmaceuticals Inc.
Via
GlobeNewswire
Tickers
INM
InMed Pharmaceuticals Advances Neurodegenerative Disease Program with Natural Sciences and Engineering Research Council of Canada ("NSERC") Alliance Grant Funding
November 16, 2022
From
InMed Pharmaceuticals Inc.
Via
GlobeNewswire
Tickers
INM
InMed Pharmaceuticals Reports First Quarter Fiscal 2023 Financial Results and Provides Business Update
November 11, 2022
From
InMed Pharmaceuticals Inc.
Via
GlobeNewswire
Tickers
INM
Registration Now Open For Tribe Public’s Webinar Event "Exploring the Neuroprotective Qualities of Rare Cannabinoids" Featuring InMed’s Management Team On November 17, 2022
November 10, 2022
From
InMed Pharmaceuticals Inc.
Via
GlobeNewswire
Tickers
INM
InMed Pharmaceuticals Supports Epidermolysis Bullosa Awareness Week
October 26, 2022
From
InMed Pharmaceuticals Inc.
Via
GlobeNewswire
Tickers
INM
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.